S SEBELA PHARMACEUTICALS
LIVE

Serial Number

88819213

Owner

SEBELA IRELAND LIMITED

Attorney

Jeffrey H. Handelsman

Filing Date

Mar 3, 2020

Add to watchlist:

No watchlists yet
View on USPTO

S SEBELA PHARMACEUTICALS Trademark

Serial Number: 88819213 • Registration: 6749663

S SEBELA PHARMACEUTICALS is a trademark filed by SEBELA IRELAND LIMITED on March 3, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

SEBELA IRELAND LIMITED (31 trademarks)

ADELAIDE CHAMBERS, PETER STREET
DUBLIN 8 , IE

Entity Type: 11

Trademark Details

Filing Date

March 3, 2020

Registration Date

June 7, 2022

Published for Opposition

March 22, 2022

Goods & Services

Pharmaceutical preparations for use in treating dermatology, gastroenterology, rheumatology, and psychiatric disorders; Pharmaceutical preparations for use in the treatment of pain and inflammation; Pharmaceutical preparations directed to women's health for use in the treatment, alleviation and prevention of thermoregulatory dysfunctions and vasomotor symptoms including hot flashes, hot flushes, night awakenings, night sweats, and such disorders and conditions associated with perimenopause, menopause and hormonal deficiencies; Menstrual symptom treatment preparations; Pharmaceutical preparations for use in treating nephrology, neurology, oncology, urology, andrology and cardiology diseases and disorders, and for use in the treatment of nasal allergies, respiratory allergies, and for use as anti-infectives; contraceptive preparations; dietary and nutritional supplements; prenatal vitamins; pharmaceutical preparations for the treatment of bone diseases; preparations for the suppression of hormones; pharmaceutical preparations directed to women's health for use in the treatment, alleviation and prevention of overactive bladder, female sexual dysfunction, infertility, endometriosis, vaginitis, osteoporosis, osteopenia, pelvic pain, dyspareunia, and candidiasis; Diagnostic agents, preparations and substances for medical purposes; all of the aforesaid goods not for use as a product name of a pharmaceutical product

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 7, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 7, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 22, 2022 NPUB
PUBLISHED FOR OPPOSITION
Mar 22, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 2, 2022 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Feb 17, 2022 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Sep 10, 2021 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 8, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 7, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 7, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 7, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 5, 2021 GNRN
NON-FINAL ACTION E-MAILED
Mar 5, 2021 GNRT
NON-FINAL ACTION WRITTEN
Mar 5, 2021 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 4, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 4, 2021 CRFA
ASSIGNED TO LIE
Mar 2, 2021 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 2, 2020 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Nov 21, 2020 GNS2
INQUIRY TO SUSPENSION E-MAILED
Nov 21, 2020 GNSI
SUSPENSION INQUIRY WRITTEN
Nov 21, 2020 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 21, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
May 21, 2020 GNSL
SUSPENSION LETTER WRITTEN
May 21, 2020 CNSL
ASSIGNED TO EXAMINER
May 21, 2020 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 10, 2020 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 9, 2020 NWOS
NEW APPLICATION ENTERED
Mar 6, 2020 NWAP